-
1
-
-
0002636468
-
Physical and metabolic characteristics of persons with diabetes
-
Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, (NIH publ. no. 95-1468)
-
Cowie CC, Harris MI: Physical and metabolic characteristics of persons with diabetes. In Diabetes in America, 2nd ed. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1995, p.117-133 (NIH publ. no. 95-1468)
-
(1995)
Diabetes in America, 2nd Ed.
, pp. 117-133
-
-
Cowie, C.C.1
Harris, M.I.2
-
2
-
-
0023232260
-
Consensus development conference on diet and exercise in non-insulin-dependent diabetes mellitus
-
Consensus Development Panel: Consensus development conference on diet and exercise in non-insulin-dependent diabetes mellitus. Diabetes Care 10:639-644, 1987
-
(1987)
Diabetes Care
, vol.10
, pp. 639-644
-
-
-
3
-
-
0028832693
-
Effects of weight loss on glucose homeostasis in NIDDM
-
Kelley DE: Effects of weight loss on glucose homeostasis in NIDDM. Diabetes Rev 3:366-377, 1995
-
(1995)
Diabetes Rev
, vol.3
, pp. 366-377
-
-
Kelley, D.E.1
-
4
-
-
0016749884
-
Maturity onset diabetes mellitus: Response to intensive dietary management
-
Hadden DR, Montgomery DAD, Skelly RJ, Trimble ER, Weaver JA, Wilson EA, Buchanan KD: Maturity onset diabetes mellitus: response to intensive dietary management. Br Med J 3:276-278, 1975
-
(1975)
Br Med J
, vol.3
, pp. 276-278
-
-
Hadden, D.R.1
Montgomery, D.A.D.2
Skelly, R.J.3
Trimble, E.R.4
Weaver, J.A.5
Wilson, E.A.6
Buchanan, K.D.7
-
5
-
-
0021266768
-
Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and athero-sclerotic risk in obese patients with type II diabetes mellitus
-
Hughes TA, Gwynne JT, Switzer BR, Herbst C, White G: Effects of caloric restriction and weight loss on glycemic control, insulin release and resistance, and athero-sclerotic risk in obese patients with type II diabetes mellitus. Am J Med 77:7-17, 1984
-
(1984)
Am J Med
, vol.77
, pp. 7-17
-
-
Hughes, T.A.1
Gwynne, J.T.2
Switzer, B.R.3
Herbst, C.4
White, G.5
-
6
-
-
0022613149
-
Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-depcndent diabetic and nondiabetic subjects
-
Henry RR, Wiest-Kent A, Scheaffer L, Kolterman OG, Olefsky JM: Metabolic consequences of very-low-calorie diet therapy in obese non-insulin-depcndent diabetic and nondiabetic subjects. Diabetes 35:155-164, 1986
-
(1986)
Diabetes
, vol.35
, pp. 155-164
-
-
Henry, R.R.1
Wiest-Kent, A.2
Scheaffer, L.3
Kolterman, O.G.4
Olefsky, J.M.5
-
7
-
-
0023888908
-
The safety and efficacy of a controlled low-energy (very-low-calorie) diet in the treatment of non-insulin dependent diabetes and obesity
-
Amatruda JM, Richeson JF, Welle SL, Brodows RG, Lockwood DH: The safety and efficacy of a controlled low-energy (very-low-calorie) diet in the treatment of non-insulin dependent diabetes and obesity Arch Intern Med 148:873-877, 1988
-
(1988)
Arch Intern Med
, vol.148
, pp. 873-877
-
-
Amatruda, J.M.1
Richeson, J.F.2
Welle, S.L.3
Brodows, R.G.4
Lockwood, D.H.5
-
8
-
-
0028856161
-
Promoting adherence to weight-loss regimens
-
Wing RW: Promoting adherence to weight-loss regimens. Diabetes Rev 3:354-365, 1995
-
(1995)
Diabetes Rev
, vol.3
, pp. 354-365
-
-
Wing, R.W.1
-
9
-
-
0028353245
-
Nutrition recommendations and principles for people with diabetes mellitus (position statement)
-
American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus (Position Statement). Diabetes Care 17:519-522, 1994
-
(1994)
Diabetes Care
, vol.17
, pp. 519-522
-
-
-
10
-
-
0027389784
-
Behavioral treatment of obesity. Its application to type II diabetes
-
Wing RR: Behavioral treatment of obesity. Its application to type II diabetes. Diabetes Care 16:193-199, 1993
-
(1993)
Diabetes Care
, vol.16
, pp. 193-199
-
-
Wing, R.R.1
-
11
-
-
0028265968
-
Nutrition principles for the management of diabetes and related complications
-
Franz MJ, Horton ES, Bantle JP, Beebe CA, Brunzell JD, Coulston AM, Henry RR, Hoogwerf BJ, Stacpoole PW: Nutrition principles for the management of diabetes and related complications. Diabetes Care 17:490-518, 1994
-
(1994)
Diabetes Care
, vol.17
, pp. 490-518
-
-
Franz, M.J.1
Horton, E.S.2
Bantle, J.P.3
Beebe, C.A.4
Brunzell, J.D.5
Coulston, A.M.6
Henry, R.R.7
Hoogwerf, B.J.8
Stacpoole, P.W.9
-
12
-
-
0030778116
-
The prevention and treatment of obesity
-
Maggio CA, Pi-Sunyer FX: The prevention and treatment of obesity. Diabetes Care 20:1744-1766, 1997
-
(1997)
Diabetes Care
, vol.20
, pp. 1744-1766
-
-
Maggio, C.A.1
Pi-Sunyer, F.X.2
-
13
-
-
10544235698
-
Long-term pharmacotherapy in the management of obesity
-
National Task Force on the Prevention and Treatment of Obesity: Long-term pharmacotherapy in the management of obesity. JAMA 276:1907-1915, 1996
-
(1996)
JAMA
, vol.276
, pp. 1907-1915
-
-
-
14
-
-
0026567087
-
Drug treatment of obesity
-
Bray GA: Drug treatment of obesity. Am J Clin Nutr 55:538S-544S, 1992
-
(1992)
Am J Clin Nutr
, vol.55
-
-
Bray, G.A.1
-
15
-
-
0021242404
-
A double-blind clinical trial in weight control
-
Weintraub M, Hasday JD, Mushlin AI, Lockwood DH: A double-blind clinical trial in weight control. Arch Intern Med 144:1143-1148, 1984
-
(1984)
Arch Intern Med
, vol.144
, pp. 1143-1148
-
-
Weintraub, M.1
Hasday, J.D.2
Mushlin, A.I.3
Lockwood, D.H.4
-
16
-
-
0026517115
-
Long-term weight control: The national heart, lung, and blood institute funded multimodal intervention study
-
Weintraub M: Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study. Clin Pharmacol Ther 51:581-646, 1992
-
(1992)
Clin Pharmacol Ther
, vol.51
, pp. 581-646
-
-
Weintraub, M.1
-
17
-
-
0030876952
-
Valvular heart disease associated with fenfluramine-phentermine
-
Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV: Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337:581-588, 1997
-
(1997)
N Engl J Med
, vol.337
, pp. 581-588
-
-
Connolly, H.M.1
Crary, J.L.2
McGoon, M.D.3
Hensrud, D.D.4
Edwards, B.S.5
Edwards, W.D.6
Schaff, H.V.7
-
20
-
-
0344999967
-
-
Rosemont, IL, National Dairy Council
-
Lifesteps. Rosemont, IL, National Dairy Council, 1995
-
(1995)
Lifesteps
-
-
-
21
-
-
0026795501
-
Metabolic effects of dietary fructose in diabetic subjects
-
Bantle JP, Swanson JE, Thomas W, Laine DC: Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care 15: 1468-1476, 1992
-
(1992)
Diabetes Care
, vol.15
, pp. 1468-1476
-
-
Bantle, J.P.1
Swanson, J.E.2
Thomas, W.3
Laine, D.C.4
-
22
-
-
8944256349
-
New methods for calculating metabolic rate with special reference to protein metabolism
-
Weir JB: New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol 109:1-9, 1949
-
(1949)
J Physiol
, vol.109
, pp. 1-9
-
-
Weir, J.B.1
-
24
-
-
0027363269
-
Use and abuse of appetite-suppressant drugs in the treatment of obesity
-
Bray GA: Use and abuse of appetite-suppressant drugs in the treatment of obesity. Ann Interm Med 119:707-713, 1993
-
(1993)
Ann Interm Med
, vol.119
, pp. 707-713
-
-
Bray, G.A.1
-
25
-
-
0024446507
-
International trial of long-term dexfenfluramine in obesity
-
Guy-Grand B, Crepaldi G, Lefebvre P, Apfelbaum M, Gries A, Turner P: International trial of long-term dexfenfluramine in obesity. Lancet 2:1142-1145, 1989
-
(1989)
Lancet
, vol.2
, pp. 1142-1145
-
-
Guy-Grand, B.1
Crepaldi, G.2
Lefebvre, P.3
Apfelbaum, M.4
Gries, A.5
Turner, P.6
-
26
-
-
0023634861
-
Long-term effects of modest weight loss in type 2 diabetic patients
-
Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D: Long-term effects of modest weight loss in type 2 diabetic patients. Arch Intern Med 147:1749-1753, 1987
-
(1987)
Arch Intern Med
, vol.147
, pp. 1749-1753
-
-
Wing, R.R.1
Koeske, R.2
Epstein, L.H.3
Nowalk, M.P.4
Gooding, W.5
Becker, D.6
-
27
-
-
0025321837
-
Prediction of glucose response to weight loss in patients with non-insulin dependent diabetes mellitus
-
Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SSP, Musey VC, Siddiq K, Phillips LS: Prediction of glucose response to weight loss in patients with non-insulin dependent diabetes mellitus. Arch Intern Med 150:803-806, 1991
-
(1991)
Arch Intern Med
, vol.150
, pp. 803-806
-
-
Watts, N.B.1
Spanheimer, R.G.2
DiGirolamo, M.3
Gebhart, S.S.P.4
Musey, V.C.5
Siddiq, K.6
Phillips, L.S.7
-
28
-
-
0019719231
-
Diminished effect of caloric restriction on control of hyperglycemia with increasing known duration of type II diabetes mellitus
-
Nagulesparan M, Savage PJ, Bennion LJ, Unger RH, Bennet PH: Diminished effect of caloric restriction on control of hyperglycemia with increasing known duration of type II diabetes mellitus. J Clin Endocrinol Metab 53:560-568, 1981
-
(1981)
J Clin Endocrinol Metab
, vol.53
, pp. 560-568
-
-
Nagulesparan, M.1
Savage, P.J.2
Bennion, L.J.3
Unger, R.H.4
Bennet, P.H.5
-
29
-
-
0022412905
-
Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus
-
Henry RR, Scheaffer L, Olefsky JM: Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 61:917-925, 1985
-
(1985)
J Clin Endocrinol Metab
, vol.61
, pp. 917-925
-
-
Henry, R.R.1
Scheaffer, L.2
Olefsky, J.M.3
-
30
-
-
0025091843
-
Drug treatment of obesity in type 2 diabetes mellitus
-
Carpenter MA, Bodansky HJ: Drug treatment of obesity in type 2 diabetes mellitus. Diabet Med 7:99-104, 1990
-
(1990)
Diabet Med
, vol.7
, pp. 99-104
-
-
Carpenter, M.A.1
Bodansky, H.J.2
-
31
-
-
0344137523
-
Effect of weight loss and dexfenfluramine on glycemic control and glucose metabolism in obese NIDDM patients
-
Damsbo P, Madsbad S, Henriksen JE, Beck-Nielsen H: Effect of weight loss and dexfenfluramine on glycemic control and glucose metabolism in obese NIDDM patients (Abstract). Diabetes 40 (Suppl. 1):307A, 1991
-
(1991)
Diabetes
, vol.40
, Issue.SUPPL. 1
-
-
Damsbo, P.1
Madsbad, S.2
Henriksen, J.E.3
Beck-Nielsen, H.4
-
32
-
-
0026549721
-
The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes
-
Willey KA, Molyneaux LM, Overland JE, Yue DK: The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes. Diabet Med 9:341-343, 1992
-
(1992)
Diabet Med
, vol.9
, pp. 341-343
-
-
Willey, K.A.1
Molyneaux, L.M.2
Overland, J.E.3
Yue, D.K.4
-
33
-
-
0027526493
-
Dexfenfluramine in type 2 diabetes: Effect on weight and diabetes control
-
Stewart GO, Stein GR, Davis TM, Findlater P: Dexfenfluramine in type 2 diabetes: effect on weight and diabetes control. J Med Aust 158:167-169, 1993
-
(1993)
J Med Aust
, vol.158
, pp. 167-169
-
-
Stewart, G.O.1
Stein, G.R.2
Davis, T.M.3
Findlater, P.4
-
34
-
-
0028145551
-
Obese patients with type 2 diabetes poorly controlled by insulin and metformin: Effects of adjunctive dexfenfluramine therapy on glycemic control
-
Willey KA, Molyneaux LM, Yue DK: Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycemic control. Diabet Med 11:701-704, 1994
-
(1994)
Diabet Med
, vol.11
, pp. 701-704
-
-
Willey, K.A.1
Molyneaux, L.M.2
Yue, D.K.3
-
35
-
-
0028288296
-
Dexfenfluramine in type 2 diabetes: Effect on weight and diabetes control
-
Walsh JP, Davis TME, Stewart GO, Stein GR, Findlater P: Dexfenfluramine in type 2 diabetes: effect on weight and diabetes control (Letter). J Med Aust 160:528, 1994
-
(1994)
J Med Aust
, vol.160
, pp. 528
-
-
Walsh, J.P.1
Davis, T.M.E.2
Stewart, G.O.3
Stein, G.R.4
Findlater, P.5
-
36
-
-
0031904104
-
Role of orlistat in the treatment of obese patients with type 2 diabetes
-
Hollander PA, Elbein SC, Hirsch IB, Kelley D, McGill J, Taylor T, Weiss SR, Crockett SE, Kaplan RA, Comstock J, Lucas CP, Lodewick PA, Canovatchel W, Chung J, Hauptman J: Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 21:1288-1291, 1998
-
(1998)
Diabetes Care
, vol.21
, pp. 1288-1291
-
-
Hollander, P.A.1
Elbein, S.C.2
Hirsch, I.B.3
Kelley, D.4
McGill, J.5
Taylor, T.6
Weiss, S.R.7
Crockett, S.E.8
Kaplan, R.A.9
Comstock, J.10
Lucas, C.P.11
Lodewick, P.A.12
Canovatchel, W.13
Chung, J.14
Hauptman, J.15
-
37
-
-
0015691088
-
Hypoglycemic action of fenfluramine in diabetes mellitus
-
Turtle JR, Burgess JA: Hypoglycemic action of fenfluramine in diabetes mellitus. Diabetes 22:858-867, 1973
-
(1973)
Diabetes
, vol.22
, pp. 858-867
-
-
Turtle, J.R.1
Burgess, J.A.2
-
38
-
-
0024577504
-
Fenfluramine increases insulin action in patients with NIDDM
-
Pestell RG, Crock PA, Ward GM, Alford FP, Best JD: Fenfluramine increases insulin action in patients with NIDDM. Diabetes Care 12:252-258, 1989
-
(1989)
Diabetes Care
, vol.12
, pp. 252-258
-
-
Pestell, R.G.1
Crock, P.A.2
Ward, G.M.3
Alford, F.P.4
Best, J.D.5
-
39
-
-
0028310816
-
Effects of dexfenfluramine on glucose turnover in non-insulin-dependent diabetes mellitus
-
Proietto J, Thorburn AW. Fabris S, Harrison LC: Effects of dexfenfluramine on glucose turnover in non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 23:127-134, 1994
-
(1994)
Diabetes Res Clin Pract
, vol.23
, pp. 127-134
-
-
Proietto, J.1
Thorburn, A.W.2
Fabris, S.3
Harrison, L.C.4
|